Thyroid considerations Cagrilintide carries a theoretical concern regarding thyroid tumors, similar to the boxed warnings on GLP-1 receptor agonists
It is available for laboratory research under research-use-only terms without a prescription
Those with weight loss exhibited overall favorable shifts in measures related to cardiometabolic risk, Pickhardt adds, also noting that decreased muscle attenuation in patients who gained weight was consistent with a decrease in muscle quality
Though these early studies are promising, clinicians still recommend stopping treatment during pregnancy
Let's take a look at some numbers
Dungan KM, Povedano ST, Forst T, Gonzalez JG, Atisso C, Sealls W, et al